Risk determination and prevention of breast cancer

Breast cancer is an increasing public health problem. Substantial advances have been made in the treatment of breast cancer, but the introduction of methods to predict women at elevated risk and prevent the disease has been less successful. Here, we summarize recent data on newer approaches to risk prediction, available approaches to prevention, how new approaches may be made, and the difficult problem of using what we already know to prevent breast cancer in populations. During 2012, the Breast Cancer Campaign facilitated a series of workshops, each covering a specialty area of breast cancer to identify gaps in our knowledge. The risk-and-prevention panel involved in this exercise was asked to expand and update its report and review recent relevant peer-reviewed literature. The enlarged position paper presented here highlights the key gaps in risk-and-prevention research that were identified, together with recommendations for action. The panel estimated from the relevant literature that potentially 50% of breast cancer could be prevented in the subgroup of women at high and moderate risk of breast cancer by using current chemoprevention (tamoxifen, raloxifene, exemestane, and anastrozole) and that, in all women, lifestyle measures, including weight control, exercise, and moderating alcohol intake, could reduce breast cancer risk by about 30%. Risk may be estimated by standard models potentially with the addition of, for example, mammographic density and appropriate single-nucleotide polymorphisms. This review expands on four areas: (a) the prediction of breast cancer risk, (b) the evidence for the effectiveness of preventive therapy and lifestyle approaches to prevention, (c) how understanding the biology of the breast may lead to new targets for prevention, and (d) a summary of published guidelines for preventive approaches and measures required for their implementation. We hope that efforts to fill these and other gaps will lead to considerable advances in our efforts to predict risk and prevent breast cancer over the next 10 years.

[1]  R. Marfella,et al.  Effect of Weight Loss and Lifestyle Changes on Vascular Inflammatory Markers in Obese Women , 2003 .

[2]  M. Bentires-Alj,et al.  How pregnancy at early age protects against breast cancer. , 2014, Trends in molecular medicine.

[3]  B. Komm,et al.  An overview of current and emerging SERMs , 2014, The Journal of Steroid Biochemistry and Molecular Biology.

[4]  G. Colditz,et al.  Prospective study of growth and development in older girls and risk of benign breast disease in young women , 2011, Cancer.

[5]  V. McCormack,et al.  Breast Density and Parenchymal Patterns as Markers of Breast Cancer Risk: A Meta-analysis , 2006, Cancer Epidemiology Biomarkers & Prevention.

[6]  P. Hartge,et al.  Effect of changing breast cancer incidence rates on the calibration of the Gail model. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[7]  H. Brinkhaus,et al.  JAK2/STAT5 inhibition circumvents resistance to PI3K/mTOR blockade: a rationale for cotargeting these pathways in metastatic breast cancer. , 2012, Cancer cell.

[8]  A. Howell,et al.  Breast cancer risk assessment in 8,824 women attending a family history evaluation and screening programme , 2013, Familial Cancer.

[9]  J. Cauley,et al.  Baseline Mammographic Breast Density and the Risk of Invasive Breast Cancer in Postmenopausal Women Participating in the NSABP Study of Tamoxifen and Raloxifene (STAR) , 2012, Cancer Prevention Research.

[10]  V Shane Pankratz,et al.  Comparison of percent density from raw and processed full-field digital mammography data , 2013, Breast Cancer Research.

[11]  D. Katsaros,et al.  Physical activity and breast cancer survival: an epigenetic link through reduced methylation of a tumor suppressor gene L3MBTL1 , 2012, Breast Cancer Research and Treatment.

[12]  S. Olson The current state of obesity solutions in the United States. Workshop Summary. , 2014 .

[13]  S. Perkins,et al.  Differential Effects of Calorie Restriction and Exercise on the Adipose Transcriptome in Diet-Induced Obese Mice , 2011, Journal of obesity.

[14]  W. Willett,et al.  Alcohol Intake Between Menarche and First Pregnancy: A Prospective Study of Breast Cancer Risk , 2013, Journal of the National Cancer Institute.

[15]  K. Brown,et al.  Cancer chemoprevention: a rapidly evolving field , 2013, British Journal of Cancer.

[16]  R. Wilkins Polygenes, risk prediction, and targeted prevention of breast cancer. , 2008, The New England journal of medicine.

[17]  M. Visser,et al.  Elevated C-reactive protein levels in overweight and obese adults. , 1999, JAMA.

[18]  S. Duffy,et al.  Critical research gaps and translational priorities for the successful prevention and treatment of breast cancer , 2013, Breast Cancer Research.

[19]  M. García-Closas,et al.  Combined associations of genetic and environmental risk factors: implications for prevention of breast cancer. , 2014, Journal of the National Cancer Institute.

[20]  B. Zheng,et al.  Bilateral mammographic density asymmetry and breast cancer risk: a preliminary assessment. , 2012, European journal of radiology.

[21]  Karla Kerlikowske,et al.  Agreement of Mammographic Measures of Volumetric Breast Density to MRI , 2013, PloS one.

[22]  Loki Natarajan,et al.  Influence of a diet very high in vegetables, fruit, and fiber and low in fat on prognosis following treatment for breast cancer: the Women's Healthy Eating and Living (WHEL) randomized trial. , 2007, JAMA.

[23]  A. LaCroix,et al.  Selective oestrogen receptor modulators in prevention of breast cancer: an updated meta-analysis of individual participant data , 2013, The Lancet.

[24]  G. Colditz,et al.  Validation of Rosner–Colditz breast cancer incidence model using an independent data set, the California Teachers Study , 2013, Breast Cancer Research and Treatment.

[25]  Heather K. Neilson,et al.  The Influence of Energetic Factors on Biomarkers of Postmenopausal Breast Cancer Risk , 2013, Current Nutrition Reports.

[26]  M. Inoue,et al.  Body weight at age 20 years, subsequent weight change and breast cancer risk defined by estrogen and progesterone receptor status—the Japan public health center‐based prospective study , 2011, International journal of cancer.

[27]  W. Willett,et al.  Folate Intake and Risk of Breast Cancer Characterized by Hormone Receptor Status , 2005, Cancer Epidemiology Biomarkers & Prevention.

[28]  F. Sotgia,et al.  JNK1 stress signaling is hyper-activated in high breast density and the tumor stroma: Connecting fibrosis, inflammation, and stemness for cancer prevention , 2014, Cell cycle.

[29]  C. Vachon,et al.  Mammographic density phenotypes and risk of breast cancer: a meta-analysis. , 2014, Journal of the National Cancer Institute.

[30]  E. Mercken,et al.  SRT2104 extends survival of male mice on a standard diet and preserves bone and muscle mass , 2014, Aging cell.

[31]  D. Marchioni,et al.  Breast cancer and dietary patterns: a systematic review. , 2014, Nutrition reviews.

[32]  J. Robertson,et al.  Development and Validation of a High Throughput System for Discovery of Antigens for Autoantibody Detection , 2012, PloS one.

[33]  D. English,et al.  Associations between Weight in Early Adulthood, Change in Weight, and Breast Cancer Risk in Postmenopausal Women , 2013, Cancer Epidemiology, Biomarkers and Prevention.

[34]  Sang Mi Ahn,et al.  Effect of weight loss on some serum cytokines in human obesity: increase in IL-10 after weight loss. , 2008, The Journal of nutritional biochemistry.

[35]  M. Shammas Telomeres, lifestyle, cancer, and aging , 2011, Current opinion in clinical nutrition and metabolic care.

[36]  David A. Hinds,et al.  Assessment of Clinical Validity of a Breast Cancer Risk Model Combining Genetic and Clinical Information , 2010, Journal of the National Cancer Institute.

[37]  Patrick Neven,et al.  Genome-wide association studies identify four ER negative–specific breast cancer risk loci , 2013, Nature Genetics.

[38]  A. Jemal,et al.  Cancer Statistics, 2007 , 2007, CA: a cancer journal for clinicians.

[39]  G. Colditz,et al.  Breast cancer risk accumulation starts early: prevention must also , 2014, Breast Cancer Research and Treatment.

[40]  C. Nickson,et al.  AutoDensity: an automated method to measure mammographic breast density that predicts breast cancer risk and screening outcomes , 2013, Breast Cancer Research.

[41]  Romayne A. Thompson,et al.  Age-related lobular involution and risk of breast cancer. , 2006, Journal of the National Cancer Institute.

[42]  Joseph P. Costantino,et al.  Update of the National Surgical Adjuvant Breast and Bowel Project Study of Tamoxifen and Raloxifene (STAR) P-2 Trial: Preventing Breast Cancer , 2010, Cancer Prevention Research.

[43]  S. Ebrahim,et al.  Multiple risk factor interventions for primary prevention of coronary heart disease. , 2000, The Cochrane database of systematic reviews.

[44]  S. Hankinson,et al.  Adult weight change and incidence of premenopausal breast cancer , 2012, International journal of cancer.

[45]  I. Gram,et al.  Adiposity, hormone replacement therapy use and breast cancer risk by age and hormone receptor status: a large prospective cohort study , 2012, Breast Cancer Research.

[46]  J. Manson,et al.  Low-fat dietary pattern and risk of colorectal cancer: the Women's Health Initiative Randomized Controlled Dietary Modification Trial. , 2006, JAMA.

[47]  L. Gaal,et al.  What is the relationship between risk factor reduction and degree of weight loss , 2005 .

[48]  Priming BCL-2 to kill: the combination therapy of tamoxifen and ABT-199 in ER+ breast cancer , 2013, Breast Cancer Research.

[49]  J. Cuzick,et al.  Anastrozole for prevention of breast cancer in high-risk postmenopausal women (IBIS-II): an international, double-blind, randomised placebo-controlled trial , 2014, The Lancet.

[50]  Karla Kerlikowske,et al.  Using Clinical Factors and Mammographic Breast Density to Estimate Breast Cancer Risk: Development and Validation of a New Predictive Model , 2008, Annals of Internal Medicine.

[51]  A. Howell,et al.  Penetrance estimates for BRCA1 and BRCA2 based on genetic testing in a Clinical Cancer Genetics service setting: Risks of breast/ovarian cancer quoted should reflect the cancer burden in the family , 2008, BMC Cancer.

[52]  J. Cuzick,et al.  Oestrogen and breast cancer: results from the WHI trial. , 2012, The Lancet. Oncology.

[53]  Emily F. Conant,et al.  Breast density and parenchymal texture measures as potential risk factors for estrogen-receptor positive breast cancer , 2014, Medical Imaging.

[54]  P. Pharoah,et al.  Public health implications from COGS and potential for risk stratification and screening , 2013, Nature Genetics.

[55]  J Benichou,et al.  Validation studies for models projecting the risk of invasive and total breast cancer incidence. , 1999, Journal of the National Cancer Institute.

[56]  A. Olshan,et al.  Body size across the life course and risk of premenopausal and postmenopausal breast cancer in Black women, the Carolina Breast Cancer Study, 1993–2001 , 2014, Cancer Causes & Control.

[57]  Adherence to WCRF/AICR cancer prevention recommendations and risk of postmenopausal breast cancer: Hastert TA, Beresford SAA, Patterson RE, et al (Fred Hutchinson Cancer Res Ctr, Seattle, WA; Univ of California, San Diego, CA) Cancer Epidemiol Biomarkers Prev 22:1498-1508, 2013 , 2014 .

[58]  C. Hudis,et al.  Molecular Pathways: Adipose Inflammation as a Mediator of Obesity-Associated Cancer , 2013, Clinical Cancer Research.

[59]  V. Moyer Medications for Risk Reduction of Primary Breast Cancer in Women: U.S. Preventive Services Task Force Recommendation Statement , 2013, Annals of Internal Medicine.

[60]  P. Brown Prevention: Targeted therapy—anastrozole prevents breast cancer , 2014, Nature Reviews Clinical Oncology.

[61]  Charlotte Kuperwasser,et al.  Obesity promotes breast cancer by CCL2-mediated macrophage recruitment and angiogenesis. , 2013, Cancer research.

[62]  T. Remer,et al.  Beyond overweight: nutrition as an important lifestyle factor influencing timing of puberty. , 2012, Nutrition reviews.

[63]  V. Moyer Using Medications to Decrease the Risk for Breast Cancer in Women: Recommendations From the U.S. Preventive Services Task Force , 2013, Annals of Internal Medicine.

[64]  C. Key,et al.  Prevalence of benign, atypical, and malignant breast lesions in populations at different risk for breast cancer. A forensic autopsy study , 1987, Cancer.

[65]  Karla Kerlikowske,et al.  Prevention of breast cancer in postmenopausal women: approaches to estimating and reducing risk. , 2009, Journal of the National Cancer Institute.

[66]  A. Sigurdsson,et al.  Common variants on chromosome 5p12 confer susceptibility to estrogen receptor–positive breast cancer , 2008, Nature Genetics.

[67]  D. Evans,et al.  Familial breast cancer: summary of updated NICE guidance , 2013, BMJ.

[68]  S. Pinder,et al.  Growth Hormone Is Secreted by Normal Breast Epithelium upon Progesterone Stimulation and Increases Proliferation of Stem/Progenitor Cells , 2014, Stem cell reports.

[69]  M. Gail,et al.  Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. , 1989, Journal of the National Cancer Institute.

[70]  P. Brown,et al.  Targeted Therapy for Breast Cancer Prevention , 2013, Front. Oncol..

[71]  Mary Wilson,et al.  Assessing Individual Breast Cancer Risk within the U.K. National Health Service Breast Screening Program: A New Paradigm for Cancer Prevention , 2012, Cancer Prevention Research.

[72]  R. Chlebowski Current concepts in breast cancer chemoprevention. , 2014, Polskie Archiwum Medycyny Wewnetrznej.

[73]  P. Villalta,et al.  DNA Adductomics , 2014, Chemical research in toxicology.

[74]  I. Gram,et al.  Insulin‐like growth factor I and risk of breast cancer by age and hormone receptor status—A prospective study within the EPIC cohort , 2014, International journal of cancer.

[75]  S. Rosso,et al.  Circulating prolactin and breast cancer risk among pre- and postmenopausal women in the EPIC cohort. , 2014, Annals of oncology : official journal of the European Society for Medical Oncology.

[76]  J. Ferlay,et al.  Recent trends in incidence of five common cancers in 26 European countries since 1988: Analysis of the European Cancer Observatory. , 2015, European journal of cancer.

[77]  Jane E. Carpenter,et al.  Genetic variation in mitotic regulatory pathway genes is associated with breast tumor grade. , 2014, Human molecular genetics.

[78]  A. McTiernan,et al.  Exercise and biomarkers for cancer prevention studies. , 2007, The Journal of nutrition.

[79]  M. Gail,et al.  Benefit/risk assessment for breast cancer chemoprevention with raloxifene or tamoxifen for women age 50 years or older. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[80]  E. Jelalian,et al.  Accelerating Progress in Obesity Prevention: Solving the Weight of the Nation , 2012 .

[81]  S. Roth,et al.  Physical Activity and Telomere Biology: Exploring the Link with Aging-Related Disease Prevention , 2011, Journal of aging research.

[82]  W. Willett,et al.  Moderate alcohol consumption during adult life, drinking patterns, and breast cancer risk. , 2011, JAMA.

[83]  A. Kristal,et al.  Adherence to WCRF/AICR Cancer Prevention Recommendations and Risk of Postmenopausal Breast Cancer , 2013, Cancer Epidemiology, Biomarkers & Prevention.

[84]  J. Manson,et al.  Nutrition and Physical Activity Cancer Prevention Guidelines, Cancer Risk, and Mortality in the Women's Health Initiative , 2014, Cancer Prevention Research.

[85]  E. Riboli,et al.  The second expert report, Food, Nutrition, Physical Activity and the Prevention of Cancer: A Global Perspective , 2007 .

[86]  J. Cuzick,et al.  Distribution of breast cancer risk from SNPs and classical risk factors in women of routine screening age in the UK , 2014, British Journal of Cancer.

[87]  Heather Spencer Feigelson,et al.  Weight Gain, Body Mass Index, Hormone Replacement Therapy, and Postmenopausal Breast Cancer in a Large Prospective Study , 2004, Cancer Epidemiology Biomarkers & Prevention.

[88]  J. Manson,et al.  Economic Return From the Women's Health Initiative Estrogen Plus Progestin Clinical Trial , 2014, Annals of Internal Medicine.

[89]  M. Thun,et al.  Performance of Common Genetic Variants in Breast-cancer Risk Models , 2022 .

[90]  G. Giles,et al.  Prospective validation of the breast cancer risk prediction model BOADICEA and a batch-mode version BOADICEACentre , 2013, British Journal of Cancer.

[91]  S. Cummings,et al.  Mammographic Breast Density and the Gail Model for Breast Cancer Risk Prediction in a Screening Population , 2005, Breast Cancer Research and Treatment.

[92]  F. Clavel-Chapelon,et al.  Premenopausal serum sex hormone levels in relation to breast cancer risk, overall and by hormone receptor status—Results from the EPIC cohort , 2014, International journal of cancer.

[93]  Richard D. Riley,et al.  A systematic review of breast cancer incidence risk prediction models with meta-analysis of their performance , 2012, Breast Cancer Research and Treatment.

[94]  Robert Tibshirani,et al.  Fataluku medicinal ethnobotany and the East Timorese military resistance , 2007, Journal of ethnobiology and ethnomedicine.

[95]  Jinbo Chen,et al.  Projecting absolute invasive breast cancer risk in white women with a model that includes mammographic density. , 2006, Journal of the National Cancer Institute.

[96]  R. Steele,et al.  Promoting Changes in Diet and Physical Activity in Breast and Colorectal Cancer Screening Settings: An Unexplored Opportunity for Endorsing Healthy Behaviors , 2013, Cancer Prevention Research.

[97]  C. Hudis,et al.  Discriminatory accuracy and potential clinical utility of genomic profiling for breast cancer risk in BRCA-negative women , 2011, Breast Cancer Research and Treatment.

[98]  Alessandro Pontillo,et al.  Effect of weight loss and lifestyle changes on vascular inflammatory markers in obese women: a randomized trial. , 2003, JAMA.

[99]  B. Rosner,et al.  A 20-year prospective study of plasma prolactin as a risk marker of breast cancer development. , 2013, Cancer research.

[100]  C Osmond,et al.  Tallness and overweight during childhood have opposing effects on breast cancer risk , 2001, British Journal of Cancer.

[101]  A. Thompson,et al.  Diabetes, metformin, and breast cancer: lilac time? , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[102]  W. Willett,et al.  Body fatness at young ages and risk of breast cancer throughout life. , 2008, American journal of epidemiology.

[103]  O. Ober Diabetes Prevention Program , 2012 .

[104]  Karla Kerlikowske,et al.  Volume of Mammographic Density and Risk of Breast Cancer , 2011, Cancer Epidemiology, Biomarkers & Prevention.

[105]  Celeste M. Nelson,et al.  Integrated morphodynamic signalling of the mammary gland , 2011, Nature Reviews Molecular Cell Biology.

[106]  M. Cazzaniga,et al.  Circulating hormones and breast cancer risk in premenopausal women: a randomized trial of low-dose tamoxifen and fenretinide , 2013, Breast Cancer Research and Treatment.

[107]  D. Stram,et al.  Dietary patterns and breast cancer risk in the California Teachers Study cohort. , 2013, The American journal of clinical nutrition.

[108]  J. Cerhan,et al.  Association of Gain and Loss of Weight before and after Menopause with Risk of Postmenopausal Breast Cancer in the Iowa Women's Health Study , 2005, Cancer Epidemiology Biomarkers & Prevention.

[109]  D. G. Hoel,et al.  ‘Hormonal’ risk factors, ‘breast tissue age’ and the age-incidence of breast cancer , 1983, Nature.

[110]  J. Buring,et al.  Circulating carotenoids and risk of breast cancer: pooled analysis of eight prospective studies. , 2012, Journal of the National Cancer Institute.

[111]  A. Miller,et al.  Adherence to cancer prevention guidelines and risk of breast cancer , 2014, International journal of cancer.

[112]  S. Hilsenbeck,et al.  Mechanism and preclinical prevention of increased breast cancer risk caused by pregnancy , 2013, eLife.

[113]  Jane E. Carpenter,et al.  Genome-wide association study identifies 25 known breast cancer susceptibility loci as risk factors for triple-negative breast cancer. , 2014, Carcinogenesis.

[114]  S. Cummings,et al.  Body mass index, serum sex hormones, and breast cancer risk in postmenopausal women. , 2003, Journal of the National Cancer Institute.

[115]  J. Hopper,et al.  Mammographic density—a review on the current understanding of its association with breast cancer , 2014, Breast Cancer Research and Treatment.

[116]  M. King,et al.  Human genetics. Mapping human history. , 2002, Science.

[117]  M. Thun,et al.  American Cancer Society Guidelines on Nutrition and Physical Activity for Cancer Prevention: Reducing the Risk of Cancer With Healthy Food Choices and Physical Activity , 2002, CA: a cancer journal for clinicians.

[118]  H. Thaler,et al.  Inhibition of Jun NH2-Terminal Kinases Suppresses the Growth of Experimental Head and Neck Squamous Cell Carcinoma , 2007, Clinical Cancer Research.

[119]  K. Strasser-Weippl,et al.  Suitable trial designs and cohorts for preventive breast cancer agents , 2013, Nature Reviews Clinical Oncology.

[120]  L. Zelek,et al.  Prospective Association between Dietary Fiber Intake and Breast Cancer Risk , 2013, PloS one.

[121]  A. Renehan,et al.  Diabetes and cancer: 5 years into the recent controversy. , 2014, European journal of cancer.

[122]  Abbas Cheddad,et al.  Enhancement of Mammographic Density Measures in Breast Cancer Risk Prediction , 2014, Cancer Epidemiology, Biomarkers & Prevention.

[123]  Graham A. Colditz,et al.  Applying What We Know to Accelerate Cancer Prevention , 2012, Science Translational Medicine.

[124]  T. Norat,et al.  Fruits and vegetables: updating the epidemiologic evidence for the WCRF/AICR lifestyle recommendations for cancer prevention. , 2014, Cancer treatment and research.

[125]  A. Howell,et al.  Energy restriction and the prevention of breast cancer , 2012, Proceedings of the Nutrition Society.

[126]  A. Ashworth,et al.  Reproducibility of estradiol and testosterone levels in postmenopausal women over 5 years: results from the breakthrough generations study. , 2014, American journal of epidemiology.

[127]  Leslie J. Sim,et al.  Accelerating Progress in Obesity Prevention: Solving the Weight of the Nation , 2012 .

[128]  E A Jones,et al.  Addition of pathology and biomarker information significantly improves the performance of the Manchester scoring system for BRCA1 and BRCA2 testing , 2009, Journal of Medical Genetics.

[129]  Benjamin D. Smith,et al.  Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States. , 2014, Cancer research.

[130]  N. Chabbert-Buffet,et al.  Selective progesterone receptor modulators and progesterone antagonists: mechanisms of action and clinical applications. , 2005, Human reproduction update.

[131]  G. Colditz,et al.  Models of breast cancer show that risk is set by events of early life: prevention efforts must shift focus. , 1995, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[132]  F. Martin,et al.  Molecular regulators of pubertal mammary gland development , 2011, Annals of medicine.

[133]  E. Schröck,et al.  Evaluating the performance of the breast cancer genetic risk models BOADICEA, IBIS, BRCAPRO and Claus for predicting BRCA1/2 mutation carrier probabilities: a study based on 7352 families from the German Hereditary Breast and Ovarian Cancer Consortium , 2013, Journal of Medical Genetics.

[134]  A. Meindl,et al.  Validation of the Manchester scoring system for predicting BRCA1/2 mutations in 9,390 families suspected of having hereditary breast and ovarian cancer , 2014, International journal of cancer.

[135]  D. Greenwood,et al.  Dietary compared with blood concentrations of carotenoids and breast cancer risk: a systematic review and meta-analysis of prospective studies. , 2012, The American journal of clinical nutrition.

[136]  J. A. Andersen,et al.  Breast cancer and atypia among young and middle-aged women: a study of 110 medicolegal autopsies. , 1987, British Journal of Cancer.

[137]  F. Berrino,et al.  Sex hormones and risk of breast cancer in premenopausal women: a collaborative reanalysis of individual participant data from seven prospective studies. , 2013, The Lancet. Oncology.

[138]  G. Giles,et al.  Using SNP genotypes to improve the discrimination of a simple breast cancer risk prediction model , 2013, Breast Cancer Research and Treatment.

[139]  G. Colditz,et al.  Priorities for the primary prevention of breast cancer , 2014, CA: a cancer journal for clinicians.

[140]  Kevin W Eliceiri,et al.  Postpartum mammary gland involution drives progression of ductal carcinoma in situ through collagen and COX-2 , 2011, Nature Medicine.

[141]  David M Nathan,et al.  10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study. , 2009, Lancet.

[142]  R. Vierkant,et al.  Novel breast tissue feature strongly associated with risk of breast cancer. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[143]  R. Peto,et al.  The fraction of cancer attributable to lifestyle and environmental factors in the UK in 2010 , 2011, British Journal of Cancer.

[144]  J. Manson,et al.  Low-fat dietary pattern and risk of invasive breast cancer: the Women's Health Initiative Randomized Controlled Dietary Modification Trial. , 2006, JAMA.

[145]  T. Sellers,et al.  Early body size and subsequent weight again as predictors of breast cancer incidence (Iowa, United States) , 1995, Cancer Causes & Control.

[146]  F Berrino,et al.  Circulating sex hormones and breast cancer risk factors in postmenopausal women: reanalysis of 13 studies , 2011, British Journal of Cancer.

[147]  J. Cuzick,et al.  Use of pharmacologic interventions for breast cancer risk reduction: American Society of Clinical Oncology clinical practice guideline. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[148]  A Howell,et al.  Evaluation of breast cancer risk assessment packages in the family history evaluation and screening programme , 2003, Journal of medical genetics.

[149]  B. Parvin,et al.  Breast fibroblasts modulate early dissemination, tumorigenesis, and metastasis through alteration of extracellular matrix characteristics. , 2013, Neoplasia.

[150]  J. Eyfjörd,et al.  Population-based study of changing breast cancer risk in Icelandic BRCA2 mutation carriers, 1920-2000. , 2006, Journal of the National Cancer Institute.

[151]  D. Miglioretti,et al.  Longitudinal measurement of clinical mammographic breast density to improve estimation of breast cancer risk. , 2007, Journal of the National Cancer Institute.

[152]  R. Muniyappa,et al.  The diabetes prevention program , 2003, Current diabetes reports.

[153]  L. Bernstein Exercise and breast cancer prevention , 2009, Current oncology reports.

[154]  V. McCormack,et al.  Childhood growth and breast cancer. , 2004, American journal of epidemiology.

[155]  Joshua Labaer,et al.  Protein microarray signature of autoantibody biomarkers for the early detection of breast cancer. , 2011, Journal of proteome research.

[156]  D M Parkin,et al.  16. The fraction of cancer attributable to lifestyle and environmental factors in the UK in 2010 , 2011, British Journal of Cancer.

[157]  M. Zwahlen,et al.  Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies , 2008, The Lancet.

[158]  A. G. Motulsky,et al.  Mapping Human History , 2002, Science.

[159]  Weiqin Jiang,et al.  Candidate mechanisms accounting for effects of physical activity on breast carcinogenesis , 2009, IUBMB life.

[160]  W. Willett,et al.  Adult weight change and risk of postmenopausal breast cancer. , 2006, JAMA.

[161]  A. Moreno-Aspitia,et al.  Current strategies for the prevention of breast cancer , 2014, Breast cancer.

[162]  Andrew W Roddam,et al.  Insulin-like growth factor 1 (IGF1), IGF binding protein 3 (IGFBP3), and breast cancer risk: pooled individual data analysis of 17 prospective studies , 2010, The Lancet. Oncology.

[163]  W. Willett,et al.  Intake of specific fruits and vegetables in relation to risk of estrogen receptor-negative breast cancer among postmenopausal women , 2013, Breast Cancer Research and Treatment.

[164]  A. Ashworth,et al.  Changes in estradiol and testosterone levels in postmenopausal women after changes in body mass index. , 2013, The Journal of clinical endocrinology and metabolism.

[165]  F. Clavel-Chapelon,et al.  Dietary fiber intake and risk of hormonal receptor-defined breast cancer in the European Prospective Investigation into Cancer and Nutrition study. , 2013, The American journal of clinical nutrition.

[166]  A. Howell,et al.  Dissociation between steroid receptor expression and cell proliferation in the human breast. , 1997, Cancer research.

[167]  S. Rosso,et al.  Circulating prolactin and breast cancer risk among pre- and postmenopausal women in the EPIC cohort. , 2014 .

[168]  Mary Beth Terry,et al.  Changes in mammographic density over time in breast cancer cases and women at high risk for breast cancer , 2014, International journal of cancer.

[169]  R. Cabo,et al.  The Search for Antiaging Interventions: From Elixirs to Fasting Regimens , 2014, Cell.

[170]  J. Rosen,et al.  On hormone action in the mammary gland. , 2012, Cold Spring Harbor perspectives in biology.

[171]  R. E. James,et al.  Postmenopausal Serum Sex Steroids and Risk of Hormone Receptor–Positive and -Negative Breast Cancer: a Nested Case–Control Study , 2011, Cancer Prevention Research.

[172]  W. Willett,et al.  Fruit and vegetable intake and risk of breast cancer by hormone receptor status. , 2013, Journal of the National Cancer Institute.

[173]  Peter Kraft,et al.  Inclusion of endogenous hormone levels in risk prediction models of postmenopausal breast cancer. , 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[174]  N. Boyd,et al.  The quantitative analysis of mammographic densities. , 1994, Physics in medicine and biology.

[175]  T. Lyons,et al.  Tamoxifen induces pleiotrophic changes in mammary stroma resulting in extracellular matrix that suppresses transformed phenotypes , 2009, Breast Cancer Research.

[176]  H. Bush,et al.  Breast Cancer Research , 1978, British Journal of Cancer.

[177]  J. Manson,et al.  Conjugated equine oestrogen and breast cancer incidence and mortality in postmenopausal women with hysterectomy: extended follow-up of the Women's Health Initiative randomised placebo-controlled trial. , 2012, The Lancet. Oncology.

[178]  S. Hankinson,et al.  Body size in early life and adult levels of insulin-like growth factor 1 and insulin-like growth factor binding protein 3. , 2011, American journal of epidemiology.

[179]  J. Manson,et al.  The Women’s Health Initiative Randomized Controlled Dietary Modification Trial , 2022 .

[180]  M. Gail Value of adding single-nucleotide polymorphism genotypes to a breast cancer risk model. , 2009, Journal of the National Cancer Institute.

[181]  J. Ranstam,et al.  Breast cancer and breastfeeding: collaborative reanalysis of individual data from 47 epidemiological studies in 30 countries, including 50 302 women with breast cancer and 96 973 women without the disease , 2002, The Lancet.

[182]  Lewis H Kuller,et al.  Menopausal hormone therapy and health outcomes during the intervention and extended poststopping phases of the Women's Health Initiative randomized trials. , 2013, JAMA.

[183]  Stephen W Duffy,et al.  A breast cancer prediction model incorporating familial and personal risk factors , 2004, Hereditary Cancer in Clinical Practice.

[184]  Magnus Rattray,et al.  Relationship between genome and epigenome - challenges and requirements for future research , 2014, BMC Genomics.

[185]  A. Howell,et al.  Reduction in apoptosis relative to mitosis in histologically normal epithelium accompanies fibrocystic change and carcinoma of the premenopausal human breast , 1992, The Journal of pathology.

[186]  Jaana M. Hartikainen,et al.  Large-scale genotyping identifies 41 new loci associated with breast cancer risk , 2013, Nature Genetics.

[187]  H M Jensen,et al.  An atlas of subgross pathology of the human breast with special reference to possible precancerous lesions. , 1975, Journal of the National Cancer Institute.

[188]  Brigid M Lynch,et al.  Physical activity and breast cancer prevention. , 2011, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.

[189]  Karen A Gelmon,et al.  Exemestane for breast-cancer prevention in postmenopausal women. , 2011, The New England journal of medicine.

[190]  Farid Jamshidian,et al.  Assessing breast cancer risk models in Marin County, a population with high rates of delayed childbirth. , 2014, Clinical breast cancer.

[191]  D. Evans,et al.  Assessing women at high risk of breast cancer: a review of risk assessment models. , 2010, Journal of the National Cancer Institute.

[192]  Nico Karssemeijer,et al.  Volumetric Breast Density Estimation from Full-Field Digital Mammograms: A Validation Study , 2014, IEEE Transactions on Medical Imaging.

[193]  Martin Wiseman,et al.  The Second World Cancer Research Fund/American Institute for Cancer Research Expert Report. Food, Nutrition, Physical Activity, and the Prevention of Cancer: A Global Perspective , 2008, Proceedings of the Nutrition Society.

[194]  Robert M Elashoff,et al.  Dietary fat reduction and breast cancer outcome: interim efficacy results from the Women's Intervention Nutrition Study. , 2007, Journal of the National Cancer Institute.

[195]  J. Cauley,et al.  Body Mass Index and the Risk for Developing Invasive Breast Cancer among High-Risk Women in NSABP P-1 and STAR Breast Cancer Prevention Trials , 2012, Cancer Prevention Research.

[196]  S. Duffy,et al.  Tamoxifen-induced reduction in mammographic density and breast cancer risk reduction: a nested case-control study. , 2011, Journal of the National Cancer Institute.

[197]  D. Greenwood,et al.  Fruits, vegetables and breast cancer risk: a systematic review and meta-analysis of prospective studies , 2012, Breast Cancer Research and Treatment.

[198]  L. Lashinger,et al.  Interacting inflammatory and growth factor signals underlie the obesity-cancer link. , 2014, The Journal of nutrition.

[199]  E. Riboli,et al.  Lifetime alcohol use and overall and cause-specific mortality in the European Prospective Investigation into Cancer and nutrition (EPIC) study , 2014, BMJ Open.

[200]  J. Lindström,et al.  Sustained reduction in the incidence of type 2 diabetes by lifestyle intervention: follow-up of the Finnish Diabetes Prevention Study , 2006, The Lancet.

[201]  Karla Kerlikowske,et al.  Prospective breast cancer risk prediction model for women undergoing screening mammography. , 2006, Journal of the National Cancer Institute.

[202]  Konstantin Strauch,et al.  Breast cancer risk assessment across the risk continuum: genetic and nongenetic risk factors contributing to differential model performance , 2012, Breast Cancer Research.

[203]  A. Roddam,et al.  Breast cancer and childhood anthropometry: emerging hypotheses? , 2005, Breast Cancer Research.